Free Widgets | Toolbar | Feedback 
Live Share Markets - Appuonline.com


Updated:19 Jun 2013 03:45:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 831.70 [ +1.01% ]TCS 1427.70 [ -1.12% ]ICICIBANK 1086.70 [ -0.39% ]

     Sensex19245.70
     22.42 0.12%

     

     Nifty5822.25
     8.65 0.15%

     

     USD/INR57.87
     -0.34 -0.59%

     

Dishman Pharmaceuticals and Chemicals Ltd :

 64.10   1.75(2.81%)

ISIN: INE353G01020  | BSE : DISHMAN  |  Industry: Pharmaceuticals - Indian - Bulk Drugs  |  Comments

Price Information
• Open 62.00
• High 64.50
• Low 62.00
• Previous Close 62.35
• Shares Traded 104755
• 52 Wk High Price 124.45
• 52 Wk High Date 05-12-2012
• 52 Wk Low Price 52.40
• 52 Wk Low Date 18-06-2012
• Face Value 2.00


Fundamentals
• Market Capital (Rs.cr) 499.53
• EPS (Rs.)(TTM) 7.80
• P/E Ratio(TTM) 7.90
• Book Value (Rs.) 91.30
• Price to Book Value 0.68
• Equity (Rs.cr.) 16.14
• Traded Value (Rs.lac) 25.53


Corporate Actions
Ex-Date Purpose (Rs.)
2011-07-14 60% Final Dividend (1.2)
2012-09-13 60% Final Dividend (1.2)
2013-07-18 60% Final Dividend (1.2)


Index Names
BSE-500


Share Tips for Dishman Pharmaceuticals and Chemicals Ltd
Market outlook : Open=Flat. Then expi (09:11AM, May 30 '13)
BUY .DISHMAN PHARMA AT 75 TG 82 SL 72 (08:43AM, May 30 '13)
India Stocks Outlook for the week - 27 (03:04PM, May 25 '13)
BUY...DISHMAN PHARMA AT .77.50 TG 80 (10:25AM, May 07 '13)
buy buy buy bharti airtel : buy bharti (01:51PM, Feb 14 '13)

Mutual funds holding in Dishman Pharmaceuticals and Chemicals Ltd
SBI Magnum Global Fund 94 - Growth
Tata Equity Opportunities Fund - Growth
Birla Sun Life Advantage Fund - Growth
SBI Magnum Sector Umbrella - Pharma Fund - Growth
ING C.U.B. Fund - Growth

Key Financials Latest Qrtr. Trailing Yr. Full Yr.
• Year End Mar, 2013 Mar, 2013 Mar, 2013
• Sales (Rs.cr) 162.10 483.58 483.58
• Net Profit (Rs.cr) 39.82 63.18 63.18
• Net Profit Var (%) 59.00 42.00 42.00
• EPS (Rs) - 7.80 7.80
• P/E Ratio - 7.90 7.90
• Operating Profit Margin - 34.60 -
• CPS (Rs.) - - 12.20
• P/C Ratio - - 5.10
• Div% - - 60.00

Announcements
20-02-2013 Dishman Pharmaceuticals and Chemicals Limited - Disclosure under SEBI Takeover Regulations
27-05-2011 Dishman Pharmaceuticals and Chemicals Limited - Dividend
01-01-2013 Dishman Pharmaceuticals and Chemicals Limited - Disclosure under SEBI Takeover Regulations
07-10-2011 Dishman Pharmaceuticals and Chemicals Limited - Disclosure under SEBI Takeover Regulations
10-04-2012 Dishman Pharmaceuticals and Chemicals Limited - Disclosure under SEBI Takeover Regulations
05-03-2013 Dishman Pharmaceuticals and Chemicals Limited - Disclosure under SEBI Takeover Regulations
30-01-2013 Dishman Pharmaceuticals and Chemicals Limited - Disclosure under SEBI Takeover Regulations
04-03-2013 Dishman Pharmaceuticals and Chemicals Limited - Disclosure under SEBI Takeover Regulation
28-02-2013 Dishman Pharmaceuticals and Chemicals Limited - Disclosure under SEBI Takeover Regulations

Gross Deliverables
Date Del. Shares Trd. Qty. Del.(%) Del. Value Turnover
18-06-2013 16728 43170 38.75 1040482 2694.04
17-06-2013 15230 41609 36.60 942737 2552.74
13-06-2013 30888 66196 46.66 1837836 4008.16
07-06-2013 18857 59628 31.62 1336018 4244.11
28-05-2013 29240 145232 20.13 2021946 10118.60



Note:

- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, % change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date & not adjusted with corporate action




Comment(s) posted on Dishman Pharmaceuticals and Chemicals Ltd

By Akash Sharma on Mar 08, 2011 09:19 PM
Dish tv ka tarhet kya hai isko kitne time tak hold karke rakh sakte hai





Hot Searches  •  neyvelilig  •  narmada  •  tatat  •  indhote  •  gtlinfra  •  thermax  •  aptech  •  venkys  •  ingersoll  •  bharti
Site Map  •  Companies  •  Learning Centre  •  Insurance  •  About  •  Contact us  •  Disclaimer
©2011 Appuonline.com

Price feed provided by www.bseindia.com & www.nseindia.com and value addition by "C-MOTS InfoTech."